Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2008
08/21/2008WO2008100618A2 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008WO2008099853A1 Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099377A2 Imiquimod production process
08/21/2008WO2008099186A1 Heterocyclic derivatives as m3 muscarinic receptors
08/21/2008WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases
08/21/2008WO2008099082A1 New aminopyrrolo[1,2-α]indole et aminopyridazino[1,6-α]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008WO2008099081A2 Novel triazabenzo[α]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008099021A1 Dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008098877A1 Process for preparing 3-alkyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4,5]decane derivative
08/21/2008WO2008098374A1 Salts, prodrugs and polymorphs of fab i inhibitors
08/21/2008WO2008057855A3 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
08/21/2008WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
08/21/2008WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives
08/21/2008WO2007100430A3 Cytisine and acetylcholine analogs and methods of treating mood disorders
08/21/2008WO2007092641A3 Method for substituted 1h-imidazo[4,5-c]pyridines
08/21/2008WO2007081889A8 Production of dolasetron
08/21/2008US20080200680 Applying heat or moisture; forming tablets
08/21/2008US20080200676 Using 3-(2-chloroethyl)-2-methyl-9-hydroxy -4H-pyrido(1,2-a)pyrimidin-4-one (CMHP) as chemical intermediate for paliperidone (9-hydroxyrisperidone); catalytic hydrogenation;
08/21/2008US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth
08/21/2008US20080200501 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone;
08/21/2008US20080200496 SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie
08/21/2008US20080200495 Pyrrolopyridine Compounds, Method of Making Them and Uses Thereof
08/21/2008US20080200494 Imidazopyridine Derivatives
08/21/2008US20080200491 1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel
08/21/2008US20080200473 GABA a receptor; hypnotic agents with a lower risk of side effects; sleep, sedative, muscle relaxant; 4-Dimethylamino-N-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-ylmethyl)-benzamide
08/21/2008US20080200470 serotonin 5-HT1A receptor agonists; N-heterocyclclediones substituted with a chroman-2-yl, 2-quinolyl, or phenoxy group; 2-[4-[(Chroman-2-yl)methylamino]butyl]-1,3-dioxoperhydroimidazo[1,5-a]pyridine; Parkinson's, cerebral damage by thromboembolitic ictus, depression, migraine, psychosis, urinary disorde
08/21/2008US20080200469 Phthalazinone derivatives
08/21/2008US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008US20080199427 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C
08/21/2008CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
08/21/2008CA2676715A1 Piperazine derivatives for treatment of ad and related conditions
08/21/2008CA2676581A1 Heterocyclic derivatives as m3 muscarinic receptors
08/21/2008CA2674097A1 New aminopyrrolo[1,2-.alpha.]indole et aminopyridazino[1,6-.alpha.]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity
08/21/2008CA2674083A1 Novel triazabenzo[.alpha.]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
08/21/2008CA2672955A1 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
08/20/2008EP1957494A2 Lactam compounds and methods of using the same
08/20/2008EP1957492A2 Substituted bicyclic pyrimidone derivatives
08/20/2008EP1957491A2 Pyrrolo (2,3-b) pyridine derivatives useful as tec kinase inhibitors
08/20/2008EP1957490A1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
08/20/2008EP1957489A2 Bis-heterocyclic imidazolyl compounds
08/20/2008EP1957488A1 3-amino-2-arylpropyl azaindoles and uses thereof
08/20/2008EP1957487A1 Novel pyridopyrazines and their use as modulators of kinases
08/20/2008EP1957486A1 Compositions and methods for modulating gated ion channels
08/20/2008EP1957458A2 5-(arylsulfonyl)-pyrazolopiperidines
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1838309B1 Chromane derivatives useful as acid pump antagonists
08/20/2008EP1745052B1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
08/20/2008EP1742947B1 6-substituted pyridoindolone derivatives production and therapeutic use thereof
08/20/2008EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
08/20/2008EP1638971B1 Preparation of substituted quinoxalines from the dianiline with 2,3-dihydroxy-1,4-dioxane
08/20/2008EP1569935B1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008EP1509521B1 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases
08/20/2008EP1451202B1 Aryl fused azapolycyclic compounds
08/20/2008EP1387681B1 Use of castanospermine derivatives for the treatment of hepatitis c
08/20/2008EP1289993B9 Caspase inhibitors and uses thereof
08/20/2008CN101248153A Foaming agents containing fluorine substituted unsaturated olefins
08/20/2008CN101248078A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
08/20/2008CN101248073A Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
08/20/2008CN101248072A 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
08/20/2008CN101248071A Bicyclic piperazines as metabotropic glutamate receptor antagonists
08/20/2008CN101248070A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/20/2008CN101248067A Oxazolidinone derivatives and use thereof as antibiotics
08/20/2008CN101248050A Organic compounds
08/20/2008CN101247853A Substituted indole compounds having NOS inhibitory activity
08/20/2008CN101247808A N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
08/20/2008CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease
08/20/2008CN101245066A Method for producing 7-alkoxyl-2, 9-diazafluorene
08/20/2008CN101245065A Method for producing benzo isoxazole derivative and midbody
08/20/2008CN100412076C New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
08/20/2008CN100411687C Adhesive patch
08/20/2008CN100411686C Visual function improving agents
08/19/2008US7414131 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
08/19/2008US7414065 Methods to modulate conditions mediated by the CXCR4 receptor
08/19/2008US7414062 such as 5-[8-(3-dimethylcarbamoyl-3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-pentanoic acid; non-opioid analgesic; side effect reduction; for stimulating opioid receptors
08/19/2008US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2294609C Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
08/19/2008CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
08/19/2008CA2241469C Tetrahydroimidazo [2,1-a] isoquinoline derivatives
08/14/2008WO2008097991A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
08/14/2008WO2008096870A1 Aza-bridged-ring compound
08/14/2008WO2008096829A1 Tricyclic compounds
08/14/2008WO2008096791A1 Acylguanidine derivative
08/14/2008WO2008096746A1 Spiro compound and use thereof
08/14/2008WO2008095964A1 Crystalline form of moxifloxacin base
08/14/2008WO2008095944A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
08/14/2008WO2008095943A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
08/14/2008WO2008095835A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
08/14/2008WO2008064255A3 Compounds modulating c-fms and/or c-kit activity and uses therefor
08/14/2008WO2008064255A2 Compounds modulating c-fms and/or c-kit activity and uses therefor
08/14/2008WO2008064093A3 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile